Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “NASH Related Cirrhosis”

30 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 30 results

Large-scale testing (Phase 3)Looking for participantsNCT06461208
What this trial is testing

A PROspective Faecal MIcrobiota tranSplantation Trial to Improve outcomEs in Patients With Cirrhosis

Who this might be right for
Liver Cirrhosis
King's College London 300
Not applicableLooking for participantsNCT04666402
What this trial is testing

Integrated Diagnostics for Early Diagnosis of Liver Disease

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseNon-alcoholic SteatohepatitisAlcoholic Liver Disease+1 more
Manchester University NHS Foundation Trust 1,200
Not applicableUnknownNCT04057287
What this trial is testing

Risk Factors of Liver Fibrosis Among First Degree Relatives of Patients With NASH Related Cirrhosis (NRC)

Who this might be right for
Liver Cirrhoses
Institute of Liver and Biliary Sciences, India 670
Not applicableLooking for participantsNCT03308916
What this trial is testing

Screening At-risk Populations for Hepatic Fibrosis With Non-invasive Markers

Who this might be right for
Liver Diseases, AlcoholicFibrosis
Maja Thiele 6,500
Not applicableWithdrawnNCT02868164
What this trial is testing

Fecal Microbiota Therapy Versus Standard Therapy in Decompensated NASH Related Cirrhosis: A Randomized Controlled Trial.

Who this might be right for
NASH Related Decompensated Cirrhosis
Institute of Liver and Biliary Sciences, India
Not applicableActive Not RecruitingNCT05740358
What this trial is testing

Liver Cirrhosis Network Cohort Study

Who this might be right for
CirrhosisCirrhosis, LiverCirrhosis Early+9 more
Northwestern University 1,222
Not applicableNot Yet RecruitingNCT06364462
What this trial is testing

Precise Evaluation Criteria for Histological Regression of NASH Fibrosis

Who this might be right for
NASHLiver Fibrosis
Beijing Friendship Hospital 220
Large-scale testing (Phase 3)Study completedNCT01371825
What this trial is testing

Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of Sebelipase Alfa in Children With Growth Failure Due to Lysosomal Acid Lipase Deficiency

Who this might be right for
Lysosomal Acid Lipase DeficiencyWolman Disease
Alexion Pharmaceuticals, Inc. 9
Not applicableStudy completedNCT04146636
What this trial is testing

Screening in Primary Care of Advanced Liver Fibrosis in NAFLD and/or Alcoholic Patients (IMPROVE Study)

Who this might be right for
NAFLDAlcohol-Related DisorderLiver Fibrosis
University Hospital, Angers 282
Not applicableUnknownNCT04493814
What this trial is testing

Study Visceral Adipose Tissue and Liver Stifness in a Retrospective Cohort of Diabetes Mellitus Patients

Who this might be right for
NAFLDType 2 Diabetes
Central Hospital, Nancy, France 86
Not applicableStudy completedNCT02031913
What this trial is testing

Prospective Cohort Study of Association of Insulin Resistance/Steatosis With Hepatic Fibrosis in CHB and NAFLD

Who this might be right for
Chronic Hepatitis BHepatic FibrosisFatty Liver
Seoul National University Boramae Hospital 500
Not applicableLooking for participantsNCT06940375
What this trial is testing

Incidence of Liver Disease-Related Outcomes in People With HIV

Who this might be right for
MAFLDLiver FibrosisMASH+3 more
Shanghai Public Health Clinical Center 320
Not applicableStudy completedNCT03663062
What this trial is testing

ObeSity Related Colorectal Adenoma Risk

Who this might be right for
Colorectal AdenomaColorectal NeoplasmColorectal Cancer+4 more
South Tyneside and Sunderland NHS Foundation Trust 1,430
Not applicableLooking for participantsNCT05699018
What this trial is testing

Screening in Primary Care of Advanced Liver Fibrosis in NAFLD And/or Alcoholic Patients

Who this might be right for
Non-alcoholic Fatty Liver Disease (NAFLD)Alcoholic Liver Disease (ALD)Liver Fibrosis
University Hospital, Angers 1,788
Testing effectiveness (Phase 2)Looking for participantsNCT05832229
What this trial is testing

Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States

Who this might be right for
CirrhosisCirrhosis, LiverCirrhosis Early+5 more
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 256
Not applicableLooking for participantsNCT05623150
What this trial is testing

CHronic Hepatopathies Associated with ALcohol Consumption and MetAbolic Syndrome

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseNon-Alcoholic SteatohepatitisAlcohol-related Liver Disease+2 more
Institut National de la Santé Et de la Recherche Médicale, France 710
Not applicableUnknownNCT02721264
What this trial is testing

Fecal Microbiota Therapy Versus Standard Therapy in NASH Related Cirrhosis.

Who this might be right for
Non Alcoholic Steatohepatitis
Institute of Liver and Biliary Sciences, India 112
Not applicableLooking for participantsNCT05974904
What this trial is testing

Association of HsCAR with MAFLD and Liver Fibrosis: a Cross-sectional Study

Who this might be right for
Metabolic Dysfunction-associated Fatty Liver DiseaseHepatic SteatosisLiver Fibrosis
Chongqing Medical University 7,000
Not applicableNot Yet RecruitingNCT06135584
What this trial is testing

Study on MAFLD-related Cirrhosis Prevention and Treatment Strategies

Who this might be right for
Metabolic Dysfunction-associated Fatty Liver DiseaseCirrhosis
The Affiliated Hospital of Hangzhou Normal University 1,000
Not applicableStudy completedNCT02234440
What this trial is testing

Effect of Metformin on Disease Progression in Patients With Cryptogenic Cirrhosis (NASH-related Cirrhosis) With Diabetes or Impaired Glucose Tolerance or Insulin Resistance

Who this might be right for
NASH Related Cirrhosis
Institute of Liver and Biliary Sciences, India 86
Load More Results